Sign in

Mireille Kamariza

@kamariza.bsky.social
151 followers 278 following 7 posts

Assistant Professor @ UCLA. Chemical probes, bacterial biology and biochemistry, diagnostics, infectious diseases. Opinions my own.

PostsRepliesMedia
Mireille Kamariza @kamariza.bsky.social · 07/10/2025
I am #recruiting for a postdocs & lab techs to dissect #TB drug resistance using advanced fluorescence #microscopy techniques. Experience in #chemicalbiology #microbiology, #molecularbiology required. Interested individuals can apply here: lnkd.in/g3nPr8pd Please share this opportunity widely!
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
010
Mireille Kamariza @kamariza.bsky.social · 26/09/2025
Come work with me at UCLA! I’m hiring #postdocs to join my lab where we’re building new tools to detect TB drug resistance using fluorescence microscopy. If you’ve got a PhD (or soon will) in microbiology/chemical biology - bonus if you’ve worked in BSL3: 👉 Apply: recruit.apo.ucla.edu/JPF10626
recruit.apo.ucla.edu
Postdoctoral Researcher
University of California, Los Angeles is hiring. Apply now!
000
Reposted by Mireille Kamariza
Megan Ranney MD MPH @meganranney.bsky.social · 09/07/2025
A small piece of good news in #publichealth today: in addition to malaria vaccines for kids age 5 month+, we now have malaria TREATMENT for babies! (Of course, we also have to pay for the treatment & make it accessible. But I will take any joy I can find.) www.washingtonpost.com/health/2025/...
washingtonpost.com
First malaria treatment for newborn babies approved for use
Malaria caused 597,000 deaths worldwide in 2023, with children under 5 accounting for 76 percent of all malaria deaths in the World Health Organization’s Africa region.
527075
Reposted by Mireille Kamariza
Mill_lab @cilialab.bsky.social · 07/07/2025
📣 Cilia Lab is growing 📣 - we have 2️⃣ open positions at @uoe-igc.bsky.social @edinburgh-uni.bsky.social for talented and motivated researchers interested in disease modelling & genetic therapies which target #RareRespiratoryDiseases at their root cause. 🧪🧪#ciliopathies #PrimaryCiliaryDyskinesia 1/4
22923
Reposted by Mireille Kamariza
Jeremy Berg @jeremymberg.bsky.social · 27/06/2025
New Science story about the beginnings of grant reinstatement. www.science.org/content/arti...
science.org
NIH will reinstate 900 grants in response to court order
Projects touching on sensitive topics such as DEI had been illegally terminated, judge found
44314
Reposted by Mireille Kamariza
Will Ratcliff @wcratcliff.bsky.social · 24/06/2025
1/27 We have a new paper out! Turns out that snowflake yeast have been hiding a secret from us - they've evolved a (very!) crude circulatory system. Not with blood vessels or a heart, but through spontaneous fluid flows powered by their metabolism. 🧪🔬 www.science.org/doi/full/10....
14356146
Mireille Kamariza @kamariza.bsky.social · 25/06/2025
Obligatory intro post as a Bluesky newbie! 👋 Here’s a recent pic of my lab at UCLA — we’re a fun, curious crew studying antimicrobial resistance and the hidden structures of microbial RNA to fight infectious diseases (especially TB). Follow along for science, stories, and snapshots from the lab! 🧬🧫
170
Mireille Kamariza @kamariza.bsky.social · 25/06/2025
Working link here! www.biorxiv.org/content/10.1...
biorxiv.org
Tre-DST: A new drug susceptibility test for Mycobacterium tuberculosis using solvatochromic trehalose probes
Tuberculosis (TB) is the most lethal cause of death from a single infectious agent. In 2024, an estimated 10 million people developed TB, nearly half a million of which were infected with drug-resista...
087
Mireille Kamariza @kamariza.bsky.social · 25/06/2025
First BlueSky post to share that the First #preprint from the Kamariza Lab is live! We develop a trehalose-based assay to report drug resistance in Mycobacterium #tuberculosis. Check it out on bioRxiv: biorxiv.org/content/10.110… #TB #diagnostic
biorxiv.org
1145